Background
==========

Cleft lip with or without cleft palate (CLP) and cleft palate only (CPO) are common birth defects of complex and heterogeneous aetiology. Previous studies suggest that folate deficiency before or during pregnancy can increase risk of clefting in the resulting offspring \[[@B1]-[@B4]\]. Folate supplementation in pregnancy has been shown to reduce the recurrence of CLP in families and to have a modest reduction in birth prevalence on a population basis \[[@B5]\]. Nevertheless this association is still controversial \[[@B6],[@B7]\]. Numerous candidate gene association studies between clefts and folate related genes have shown mixed results and include methylenetetrahydrofolate reductase (*MTHFR* \[Genbank: NP_005948.3\]) \[[@B4],[@B8]-[@B16]\], methylenetetrahydrofolate dehydrogenase (NADP + dependent) (*MTHFD1* \[Genbank: NP_005947.3\]) \[[@B1],[@B16],[@B17]\], 5,10-methenyltetrahydrofolate synthetase (*MTHFS* \[Genbank: NP_001186689.1\]) and methionine synthase (*MTR* \[Genbank: NP_000245.2\]) \[[@B4],[@B17]-[@B19]\]. However, candidate gene studies to date have not considered *MTHFD1L* \[Genbank: NP_001229696.1\] in relation to nonsyndromic clefts. Environmental factors were reported for this cohort previously \[[@B16]\] and included data on the mother's medication use, folic acid exposure, alcohol and smoking. No interaction between genotype and these environmental factors were found in that study.

Based on its association with neural tube defects (NTDs) \[[@B20]\], and the previously detected association of its cytoplasmic homologue MTHFD1 in our cleft cohort, we considered the mitochondrial enzyme MTHFD1L to be a prime candidate for consideration for association with cleft. The relevance of this gene is increasing given its identification in genome wide association screens as being associated with coronary artery disease \[[@B21],[@B22]\] and Alzheimer's disease \[[@B23]\]. Moreover a previous study has shown that MTHFD1L is upregulated in human colon adenocarcinoma \[[@B24]\]. The *MTHFD1L* gene encodes the mitochondrial C1-Tetrahydrofolate(THF) Synthase protein which has a monofunctional 10-formyl-THF synthetase activity while lacking the 5,10-methylene-THF dehydrogenase and 5,10-methenyl-THF cyclohydrolase activities typically found in the trifunctional cytoplasmic protein encoded by MTHFD1 \[[@B25]\]. It has been shown that the *MTHFD1L* gene produces 2 alternatively spliced mRNAs with the shorter transcript lacking synthetase activity \[[@B26]\]. Previously, we reported that the *MTHFD1L* rs3832406 DIP and numerous SNPs in linkage disequilibrium (LD) are associated with the risk of NTDs in the Irish population \[[@B20]\]. We proposed that the DIP polymorphism is the direct disease causing variant within the associated LD block by affecting alternative splicing of the gene \[[@B20]\].

In this study, we genotyped the *MTHFD1L* DIP rs3832406 and the most statistically significant NTD-associated SNP in the adjacent LD block i.e., rs17080476, in 981 Irish case-parent trios affected by CPL or CPO. We developed a melting curve method capable of genotyping deletion/insertion polymorphisms without the need for capillary electrophoresis.

Methods
=======

Subjects
--------

Buccal swab or blood samples were obtained at the Dublin Cleft Centre in Ireland as previously described \[[@B16]\] from subjects with cleft palate only (CPO) or cleft lip with or without cleft palate (CLP) along with their mothers and fathers. A total of 2,688 samples including 758 complete triads and 223 incomplete triads were collected for this study. Out of the total number of cleft cases this included 347 (33.8%) isolated CPO cases plus an additional 108 (10.5%) with multiple defects and 531 (51.7%) isolated CLP cases plus an additional 42 (4%) with multiple defects. All the cases of this study were non-syndromic. Multiple cases included children with one or multiple defects along with cleft. Chromosomal anomalies and other conditions (i.e. mother had diabetes or epilepsy or was exposed to potentially teratogenic drugs) were excluded. Control samples (n = 1,008) were collected from a population of 56,049 pregnant women attending the three main maternity hospitals in the Dublin area between 1986 and 1990 as previously described \[[@B16],[@B27]\]. Written informed consent was obtained from all participants. Ethical approval was granted by the Research Ethics Committees of the Health Research Board of Ireland, the participating hospitals, and the Institutional Review Board at NIH.

Genotyping
----------

Genomic DNA was extracted from blood or buccal swab collected samples using a QIAamp DNA Blood Mini Kit (Qiagen, UK). HybProbe melting curve assays were designed to genotype DIP rs3832406 and SNP rs17080476 on a LightCycler 480 Real Time PCR machine (Roche) and are described in more detail below. Genotyping quality was verified by repeat genotyping of at least 10% of samples with agreement rate of ≫99% and overall success rate of ≫99%. In addition, 10% of the controls were genotyped by the HybProbe melting curve assays described here and compared to the assays used previously \[[@B20]\]. Comparison of control genotype calls gave a 95.7% agreement for DIP rs3832406 and 99% agreement for SNP rs17080476. All discrepant genotype calls for any sample were resolved by re-genotyping or were left out of the final analysis.

SNP rs17080476 assay
--------------------

SNP rs17080476 reagents and analysis conditions are: Forward Primer 5′-GCAACTTTGTTTAGTATGAAAATTTGAT-3′ (4 μM), reverse primer5′-TCTGTCTTCACCCAGCC (2 μM), anchor probe 5′-Bodipy630/650-AAGAGGGGAAAAAAAACCTTTCTCCATTATTCCTA-PHO-3′(0.4 μM), sensor probe 5′-ATTCATTTCTTTACAGCAGTGGGATTATGAAA-Fluorescein 3′ (0.2 μM), pre-incubation 10 minutes at 95°C, amplification 45 cycles of 15 seconds at 95°C, 15 seconds at 56°C, 15 seconds at 72°C, melting curve 1 minute at 95°C, 2 minutes at 50°C, acquisition ramp up to 80°C (0.11°C/s, 5 acquisitions per°C).

DIP rs3832406 assay
-------------------

DIP rs3832406 reagents and analysis conditions are: forward primer 5′-AAGCTTCCTGTTACCAC-3′ (4 μM), reverse primer 5′-AGGAGAATCACTTCAACC-3′ (2 μM), anchor probe: 5′-AGCCCCACGTTTGAATTTTATGTTTTTCCTAAAGT-Fluorescein-3′ (0.2 μM). Sensor probe: 5′BODIPY630/650-AGGGAAGATTATTATTATTATTATTATTATTATTTTCTTTTTCAGACGGA-Phosphate-3′ (0.2 μM),pre-incubation 10 minutes at 95°C, amplification 45 Cycles of 10 seconds at 95°C, 10 seconds at 56°C, 10 seconds at 72°C, melting curve 10 seconds at 95°C, 1 minute at 50°C, acquisition ramp up to 70°C (0.02°C/s, 30 acquisitions per°C).

Statistical methods
-------------------

Power calculations to detect an odds ratio of 1.5 assuming a dominant model for the case--control analyses were as follows: rs3832406 Allele 1 60%, Allele 2 95%, Allele 3 93%; rs17080476 G 95%. Assuming a recessive model: rs3832406 Allele 1 96%, Allele 2 36%, Allele 3 23%; rs17080476 G 34%. Our primary analysis was carried out with isolated nonsyndromic cases of CLP and CPO and their parents. A secondary analysis was then carried out including nonsyndromic cleft cases with other defects. Hardy-Weinberg equilibrium (HWE) was tested within each subject class (case, mother, father and controls) for each polymorphism by chi-squared test. Associations with CLP and CPO were tested for each polymorphism in cases/controls and separately in mothers/controls by logistic regression and odds ratios using either a dominant or recessive genetic disease model. Triads (case, mother, and father) were used to perform the Transmission Disequilibrium Test (TDT) of Spielman *et al*. \[[@B28]\]. The TDT P-values were adjusted using permutational correction \[[@B29]\].

Results and discussion
======================

Development of a novel assay to genotype DIP rs3832406 by Melting Curve Analysis
--------------------------------------------------------------------------------

The *MTHFD1L* gene has received particular attention in recent years owing to its association with coronary artery disease, Alzheimer's disease and NTDs. Our previous study, demonstrated that the *MTHFD1L* rs3832406 DIP is functional by impacting on alternative splicing efficiency \[[@B20]\]. We report a new modified melting curve assay to genotype this functionally relevant triallelic *MTHFD1L* polymorphism without the need for traditional capillary electrophoresis methods. A single assay which is able to distinguish 3 alleles contemporaneously was developed taking advantage of the GC-rich regions flanking the DIP (Figure [1](#F1){ref-type="fig"}). As described previously \[[@B20]\], this polymorphism is a repeated "ATT" sequence that has three common alleles, Allele 1 (ATT~7~) Allele2 (ATT~8~) and Allele 3 (ATT~9~). A wide 50-base sensor probe was designed to perfectly match Allele 3 with 9 ATT repeats and its flanking regions, producing a melting temperature (Tm) of 63°C (Figure [1c](#F1){ref-type="fig"}). The same probe produces a 3-base mismatched bubble on Allele 2 and a 6-base mismatched bubble on Allele 1 causing a Tm of 60.3°C and 58.8°C respectively (Figure [1a-b](#F1){ref-type="fig"}). The probe pairing starts from the GC-rich external regions allowing the formation of an internal mismatched bubble for Alleles 1 and 2. A slow acquisition ramp allowed melting peaks for each homozygote and heterozygote genotype to be distinguished (Figure [1d-e](#F1){ref-type="fig"}).

![**Modified Melting Curve Analysis for DIP rs3832406.** The Sensor probe design for detection of all three alleles of DIP rs3832406 is shown. The Sensor probe is designed to perfectly match the complement of Allele 3. A. Sensor probe bound to Allele 1 has a Tm of 58.8°C. B. Sensor probe bound to Allele 2 has a Tm of 60.3°C. C. Sensor probe bound to Allele 3 has a Tm of 63°C. D. Examples of homozygote melting peaks for each of the three alleles. E. Examples of heterozygote melting peaks for all three allele combinations.](1471-2350-13-29-1){#F1}

DIP rs3832406, SNP rs17080476 and risk of CLP
---------------------------------------------

We genotyped rs3832406 DIP and SNP rs17080476 in an Irish cleft cohort in a bid to test for association. The genotype frequencies of SNP rs17080476 and DIP rs3832406 in our CLP, CPO and control samples are shown in Table [1](#T1){ref-type="table"}. Genotype distributions in all groups were in HWE. DIP rs3832406 showed an association with CLP case status based on TDT analysis (Table [2](#T2){ref-type="table"}). The TDT analysis showed that Allele 1 is transmitted to the offspring 55.2% of times (p = 0.037) in isolated CLP cases, indicating that this allele is associated with increased disease risk. The addition of multiple case families to this analysis enhances the statistical significance (56.1% transmission, p = 0.011). Allele 3 has the lowest frequency and was passed to the offspring only 42.8% of times (p = 0.035) in multiple CLP cases, appearing to have a protective role against the disease. However, correction of these significant p-values using permutational adjustment resulted in loss of statistical significance. We did not observe statistical significance with SNP rs17080476 which shares a D' value of 0.61 with DIP rs3832406 and represented the most statistically compelling variant from this genomic region in our NTD study \[[@B20]\] (Table [2](#T2){ref-type="table"}). The majority of other analyses performed showed no significant association with the risk of cleft (Table [3](#T3){ref-type="table"}).

###### 

***MTHFD1L*Genotyping Results in Triads (Cases, Mother and Fathers) and Controls for CLP and CPO (Isolated) or with Other Defects (Multiple)**

  **DIPrs3832406**     Isolated defects   Multiple defects                                                                                         
  ------------------- ------------------ ------------------ ------- --------- --------- ------- ---------- ------ ----- ------ ----- ------ ------ ------
  **CLP**                  Fathers            Mothers        Cases   Fathers   Mothers   Cases   Controls                                          
                             *n*                 \%           *n*      \%        *n*      \%       *n*       \%    *n*    \%    *n*    \%    *n*     \%
  11                         162                41.8          187     40.1       209     41.9      174      42.0   203   40.8   231   43.5   419    42.1
  12                         102                26.3          128     27.5       149     29.9      116      28.0   140   28.1   163   30.7   267    26.8
  13                          76                19.6          89      19.1       84      16.8       82      19.8   97    19.5   91    17.1   196    19.7
  22                          18                4.6           24       5.2       18       3.6       18      4.3    24    4.8    18    3.4     40    4.0
  23                          24                6.2           31       6.7       28       5.6       24      5.8    34    6.8    28    5.3     52    5.2
  33                          6                 1.5            7       1.5       11       2.2       6       1.4     7    1.4    11    2.1     21    2.1
  Total                      388                              466                499               420             505          542          995      
  **CPO**                  Fathers            Mothers        Cases   Fathers   Mothers   Cases                                                     
                             *n*                 \%           *n*      \%        *n*      \%       *n*       \%    *n*    \%    *n*    \%             
  11                          98                37.3          118     38.1       134     41.7      145      40.8   154   36.9   175   41.0            
  12                          78                29.7          82      26.5       88      27.4       97      27.3   110   26.4   118   27.6            
  13                          60                22.8          69      22.3       62      19.3       77      21.7   99    23.7   86    20.1            
  22                          8                 3.0           12       3.9        7       2.2       8       2.3    18    4.3     9    2.1             
  23                          18                6.8           20       6.5       23       7.2       25      7.0    26    6.2    29    6.8             
  33                          1                 0.4            9       2.9        7       2.2       3       0.8    10    2.4    10    2.3             
  Total                      263                              310                321               355             417          427                   
  **SNPrs17080476**    Isolated defects   Multiple defects                                                                                         
  **CLP**                  Fathers            Mothers        Cases   Fathers   Mothers   Cases   Controls                                          
                             *n*                 \%           *n*      \%        *n*      \%       *n*       \%    *n*    \%    *n*    \%    *n*     \%
  AA                         268                68.2          296     63.1       320     63.1      285      67.1   320   62.9   344   62.5   660    65.9
  AG                         110                28.0          160     34.1       170     33.5      124      29.2   176   34.6   188   34.2   308    30.8
  GG                          15                3.8           13       2.8       17       3.4       16      3.8    13    2.6    18    3.3     33    3.3
  Total                      393                              469                507               425             509          550          1001     
                       Isolated defects   Multiple defects                                                                                         
  **CPO**                  Fathers            Mothers        Cases   Fathers   Mothers   Cases                                                     
                             *n*                 \%           *n*      \%        *n*      \%       *n*       \%    *n*    \%    *n*    \%             
  AA                         173                65.5          205     65.7       214     65.6      234      65.9   274   65.6   288   66.8            
  AG                          86                32.6          93      29.8       100     30.7      115      32.4   127   30.4   125   29.0            
  GG                          5                 1.9           14       4.5       12       3.7       6       1.7    17    4.1    18    4.2             
  Total                      264                              312                326               355             418          431                   

###### 

TDT analysis for DIP rs3832406 and SNP rs17080476 in all cleft sample

                                           Allele   Passed   Not Passed   GRR^1^ (95% CI)      P-value                       
  -------------------- ------------------ -------- -------- ------------ ----------------- ---------------- ---------------- --------
   **DIP rs3832406**                                 *n*         \%             *n*               \%                             
    **Isolated CLP**           1            194      55.6       155            44.4         1.3 (1.0, 1.5)     **0.0372**    
           2                  119           47.2     133        52.8      0.9 (0.7, 1.1)        0.3781                       
           3                   88           43.8     113        56.2      0.8 (0.6, 1.0)        0.0786                       
                             Total          401                 401                                                          
    **Multiple CLP**           1            216      56.5       166            43.5         1.3 (1.1, 1.6)     **0.0107**    
           2                  128           46.5     147        53.5      0.9 (0.7, 1.1)        0.2523                       
           3                   92           42.8     123        57.2       0.7 (0.6,1.0)      **0.0351**                     
                             Total          436                 436                                                          
    **Isolated CPO**           1            145      52.5       131            47.5         1.1 (0.9, 1.4)       0.3996      
           2                   86           47.8      94        52.2      0.9 (0.7, 1.2)        0.5511                       
           3                   77           48.1      83        51.9      0.9 (0.7, 1.3)        0.6353                       
                             Total          308                 308                                                          
    **Multiple CPO**           1            188      52.2       172            47.8         1.1 (0.9, 1.3)       0.3992      
           2                  115           48.9     120        51.1      1.0 (0.7, 1.2)        0.7443                       
           3                  101           47.4     112        52.6      0.9 (0.7, 1.2)        0.4512                       
                             Total          404                 404                                                          
   **SNP rs17080476**   **Isolated CLP**     G       132        54.3            111              45.7        1.2 (0.9, 1.5)   0.1785
           A                  111           45.7     132        54.3                                                         
                             Total          243                 243                                                          
    **Multiple CLP**           G            144      54.3       121            45.7         1.2 (0.9, 1.5)       0.1582      
           A                  121           45.7     144        54.3                                                         
                             Total          265                 265                                                          
    **Isolated CPO**           G             87      50.6        85            49.4         1.0 (0.8, 1.4)       0.8788      
           A                   85           49.4      87        50.6                                                         
                             Total          172                 172                                                          
    **Multiple CPO**           G            119      50.9       115            49.1         1.0 (0.8, 1.3)       0.7937      
           A                  115           49.1     119        50.9                                                         
                             Total          234                 234                                                          

^1^ GRR = genotype relative risk

^2^ CI = confidence interval

^3^ Significant values are marked in bold.

###### 

Logistic regression analysis of case/controls and mother/controls for DIP rs3832406 and SNP rs17080476 in all cleft samples

                      **Polymorphism/Allele**      **Name**        **Dominant**      **Recessive**    **Multiplicative**                                  
  ------------------ ------------------------- ---------------- ------------------- ---------------- -------------------- ---------------- -------------- ---------
                                                                 OR^1^(95% CI^2^)       p- value          OR(95% CI)          p-value       OR (95% CI)    p-value
   **Isolated CLP**        DIP Allele 1           Case-CTRL       1.1 (0.8, 1.5)         0.6159          1 (0.8, 1.3)          0.8468       1 (0.9, 1.2)   0.7022
                            Mother-CTRL         0.9 (0.6, 1.2)        0.3917         0.9 (0.7, 1.1)         0.4774         0.9 (0.8, 1.1)      0.3476     
     DIP Allele 2            Case-CTRL          1.1 (0.9, 1.4)        0.3358         0.8 (0.5, 1.4)         0.4926         1.1 (0.9, 1.3)      0.5534     
                            Mother-CTRL         1.1 (0.9, 1.4)        0.2363          1.2 (0.7, 2)          0.5077         1.1 (0.9, 1.4)      0.2176     
     DIP Allele 3            Case-CTRL          0.9 (0.7, 1.1)        0.1928           1 (0.5, 2)           0.9158         0.9 (0.7, 1.1)      0.2349     
                            Mother-CTRL          1 (0.8, 1.3)         0.9044         0.7 (0.3, 1.5)         0.3311          1 (0.8, 1.2)       0.8726     
         SNP                 Case-CTRL           1 (0.6, 1.8)         0.9798         0.9 (0.7, 1.1)         0.1816         0.9 (0.7, 1.1)      0.2494     
                            Mother-CTRL         1.3 (0.7, 2.5)        0.4286         0.9 (0.7, 1.1)         0.2382         0.9 (0.8, 1.1)      0.4336     
   **Multiple CLP**        DIP Allele 1           Case-CTRL        1 (0.7, 1.4)          0.9697          1 (0.8, 1.2)          0.9333       1 (0.8, 1.2)   0.9358
                            Mother-CTRL         0.8 (0.6, 1.2)        0.2857         0.9 (0.7, 1.2)         0.4737         0.9 (0.8, 1.1)      0.2955     
     DIP Allele 2            Case-CTRL          1.1 (0.9, 1.4)         0.258         0.9 (0.5, 1.6)         0.6969         1.1 (0.9, 1.3)      0.4046     
                            Mother-CTRL         1.1 (0.9, 1.4)        0.2396         1.3 (0.8, 2.2)         0.3264         1.1 (0.9, 1.4)      0.1809     
     DIP Allele 3            Case-CTRL          0.9 (0.7, 1.1)         0.323          1 (0.5, 2.2)          0.9053         0.9 (0.7, 1.1)      0.3998     
                            Mother-CTRL          1 (0.8, 1.3)         0.9303         0.7 (0.3, 1.7)         0.4316          1 (0.8, 1.2)       0.8883     
         SNP                 Case-CTRL           1 (0.5, 1.8)         0.9538         0.9 (0.7, 1.1)         0.2786         0.9 (0.8, 1.1)      0.3381     
                            Mother-CTRL         1.2 (0.6, 2.3)        0.5906         0.9 (0.7, 1.1)         0.2905         0.9 (0.8, 1.1)      0.4526     
   **Isolated CPO**        DIP Allele 1           Case-CTRL        1 (0.7, 1.4)          0.9498          1 (0.8, 1.2)          0.6933       1 (0.8, 1.2)   0.7915
                            Mother-CTRL         0.9 (0.6, 1.2)        0.3981          0.8 (0.6, 1)          0.0708          0.9 (0.7, 1)       0.0808     
     DIP Allele 2            Case-CTRL           1 (0.8, 1.3)         0.8703         0.5 (0.2, 1.1)         0.0749          1 (0.8, 1.2)       0.6497     
                            Mother-CTRL          1 (0.8, 1.3)         0.7614         1.1 (0.6, 1.9)         0.798           1 (0.8, 1.3)       0.7284     
     DIP Allele 3            Case-CTRL          1.1 (0.9, 1.4)        0.3873         1.1 (0.5, 2.4)         0.7843         1.1 (0.9, 1.4)      0.3963     
                            Mother-CTRL          1.3 (1, 1.7)    **0.0431**^**3**^   1.1 (0.5, 2.4)         0.7368          1.2 (1, 1.5)       0.0576     
         SNP                 Case-CTRL          0.8 (0.4, 1.4)        0.4111          1 (0.8, 1.3)          0.7454          1 (0.8, 1.2)         1        
                            Mother-CTRL         0.8 (0.4, 1.5)        0.4739          1 (0.8, 1.3)          0.8894          1 (0.8, 1.2)       0.7186     
   **Multiple CPO**        DIP Allele 1           Case-CTRL        1 (0.7, 1.5)          0.9335          1 (0.8, 1.3)          0.9081       1 (0.8, 1.2)   0.8998
                            Mother-CTRL         0.8 (0.6, 1.2)        0.3735         0.8 (0.7, 1.1)         0.2065         0.9 (0.7, 1.1)      0.1723     
     DIP Allele 2            Case-CTRL           1 (0.8, 1.3)         0.8253         0.5 (0.2, 1.2)         0.1285          1 (0.8, 1.2)       0.7474     
                            Mother-CTRL          1 (0.8, 1.3)          0.824          1 (0.5, 1.9)          0.9076          1 (0.8, 1.3)       0.882      
     DIP Allele 3            Case-CTRL          1.1 (0.8, 1.4)        0.5704          1 (0.4, 2.5)          0.9392         1.1 (0.8, 1.4)      0.598      
                            Mother-CTRL         1.2 (0.9, 1.6)        0.1179         1.4 (0.6, 3.1)         0.4179          1.2 (1, 1.6)       0.1044     
         SNP                 Case-CTRL          0.9 (0.5, 1.7)        0.7393          1 (0.8, 1.3)          0.9235          1 (0.8, 1.2)       0.847      
                            Mother-CTRL         0.7 (0.4, 1.4)        0.3247          1 (0.8, 1.3)          0.9406          1 (0.8, 1.2)       0.6925     

^1^ OR = odds ratio

^2^ CI = confidence interval

^3^ Significant values are marked in bold.

Conclusion
==========

Our analysis shows no strong association between specific polymorphisms within the *MTHFD1L* gene and risk of cleft in an Irish cohort. The main limitation of our study would be sample size and the uncorrected p-values do indicate a possible association between the rs3832406 DIP and risk of CLP. However, we suggest further screening of rs3832406 DIP in a larger cohort and describe a new assay that will facilitate this. We have demonstrated that the modified Melting Curve Analysis developed for DIP rs3832406 could be a valid alternative to capillary electrophoresis for the genotyping of multiple allele deletion/insertion polymorphisms and can be employed by any laboratory with a Real-Time PCR instrument with melting curve capacity.
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